Antihistamines as an early treatment for Covid-19

Antihistamines as an early treatment for Covid-19

Background: Infection with SARs-COV-2 results in COVID-19 disease.Between March 2020 and August 2021, 468 COVID-19 patients confirmed by PCR or antigen test, in Yepes, Spain, received early treatment with antihistamines, adding azithromycin in selected cases. The primary endpoint is the hospitalizat...

Full description

Bibliographic Details
Main Authors: Juan Ignacio Morán Blanco, Judith A. Alvarenga Bonilla, Philip Fremont-Smith, Karina Villar Gómez de las Heras
Format: Article
Language:English
Published: Elsevier 2023-05-01
Series:Heliyon
Subjects:
SARS-CoV-2
Coronavirus
Azithromycin
Antihistamines
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844023029791

Similar Items

Similar Items